Correction Revenue should read $4.6 m Not $46.

First 50 Last

Share
Profile

Follow
kwok

295 Posts.

23

20/12/15

16:27

Post #: 16654097
Share

Originally posted by kwok ↑

Hi Guys
English is not my first language so please don't pick on me.I am confused perhaps believe that a profit update is warranted on the basis of the following announcements

Ann on 28/9/2015 Company said

Release 4 new products

1200 new customers signed during soft landing
new revenue to add $1m over 12 months
Distribution and partnership agreement with leading carriers and more than 350 channels partners including Telstra Vocus Mynetfone M2 and ISphone
Marketing campaign in Q4 2015

Ann on 6/10/2015 Company said

Record 22% annual revenue increase for 2015
Majority of customers are under long term contract
Combined revenue of $46m

Ann on 3/11/2015 Company said that global non exclusive agreement with Rhino Co Technology will

Add more than 1200 new active channel partners worldwide
Increase Vonex PBX distribution network by more than 340%
Resell Vonex PBX and actively recommend to its clients potentially more than trebling Vonex current network

I believe that the financial benefits from the ann of 3/11/2015 alone will make any previous profit forecast obsolete as the deal with Rhino is extremely significant in terms of profitability and cash flow and Management should notify the AXS as A2m did last week.This I honestly hope they will do .asap soon after relisting . IMHO Vonex has an enormous future and I am very excited to be part of it
I love to hear what others have to say or think as this is an open forum.
Regards

Expand

Correction Revenue should read $4.6 m Not $46.

AWD Price at posting: 0.0¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals